Medihauxe Pharma Private Limited

Medihauxe Pharma Private Limited - pharma in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24233TG2014PTC094068 Incorporated 16 May 2014 ROC Hyderabad HQ Hyderabad, Telangana, India
Merged Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹175.69 Cr
▼ 4% YoY
Net profit · FY 2023
₹2.19 Cr
Net margin 1.2%
EBITDA · FY 2023
₹6.44 Cr
EBITDA margin 3.7%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Satisfied charges
₹31 Cr
No open charges
Company age
12 yrs
Est. 2014
Employees · EPFO
67
Provident fund records

About Medihauxe Pharma Private Limited

Data last updated:

Medihauxe Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Keimed Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 May 2014.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2014PTC094068. Its GSTIN is 36AAJCM2250J1ZF (Telangana). The company held 4 GST registrations, of which 3 are active.

The company had an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.5 Cr. It was led by directors including Girishbhat Padukudru (Managing Director) and Manohar Bhat Padakuduru (Whole-Time Director).

Its last annual general meeting (AGM) was held on 08 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Mig – 7/A Mch No – 7 – 1 – 397/102(7(A)) Near Community Hall S R Nagar, Hyderabad, Telangana, India – 500038.

As per the financials filed for FY 2023, the company reported a revenue of ₹175.69 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹2.19 Cr (net margin 1.2%) and EBITDA of ₹6.44 Cr (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 11% over five years.

The company had about 67 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 1 subsidiary.

The company was associated with 1 brand: Medihauxe Pharma. As per MCA filings, the company had satisfied charges of ₹31 Cr on record. Court records list 20 cases involving the company, including 13 filed by the company and 7 filed against it; 4 cases are pending. The company has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in February 2016. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 3 smaller; the largest is Dadha Pharma Distribution Limited with revenue of ₹182.54 Cr. The company has 2 MSME Form 1 returns on record between 2018 and 2019, listing 2 overdue payments to 2 micro and small suppliers.

The last known website on record is medihauxepharma.com.

Company details

CIN U24233TG2014PTC094068
Registration Number 094068
Incorporation Date 16 May 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 08 September 2023
Date of Balance Sheet 31 March 2023
Parent Company Keimed Private Limited
Compliance Status Active Compliant

CIN history

Medihauxe Pharma has one previous CIN (Corporate Identification Number): U24233AP2014PTC094068. The current CIN is U24233TG2014PTC094068, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24233TG2014PTC094068Current
U24233AP2014PTC094068Previous

Contact details

Medihauxe Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is medihauxepharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Mig – 7/A Mch No – 7 – 1 – 397/102(7(A)) Near Community Hall S R Nagar, Hyderabad, Telangana, India – 500038
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Medihauxe Pharma Private Limited, buy the company report.

Comprehensive company report
Medihauxe Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Medihauxe Pharma operates one associated brand: Medihauxe Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical distribution of life-saving medicines, focusing on oncology in India.medihauxepharma.com

Business activity

The main business activity of Medihauxe Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medihauxe Pharma Private Limited, buy the company report.

Financials of Medihauxe Pharma Private Limited

FY 2023 filings available

Medihauxe Pharma Private Limited reported revenue of ₹175.69 Cr (down 4% YoY) for FY 2023.

Revenue · FY 2023
₹175.69 Cr ▼ 4%
Net profit · FY 2023
₹2.19 Cr margin 1.2%
EBITDA · FY 2023
₹6.44 Cr margin 3.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 13%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 18%
5 years · compounded
▲ 8%

Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹175.69 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.44 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.19 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin3.7%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medihauxe Pharma Private Limited, buy the company report.

Board of directors of Medihauxe Pharma Private Limited

Medihauxe Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Arvind Kumar VenkatNominee Director11 Sep 201412 Years 1 MonthsAs last reported
Girishbhat PadukudruManaging Director16 May 201412 Years 5 MonthsAs last reported
Manohar Bhat PadakuduruWhole-Time Director16 May 201412 Years 5 MonthsAs last reported
Yashwant SinghDirector07 Sep 20206 Years 1 MonthsAs last reported

Peer comparison

Medihauxe Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dadha Pharma Distribution Limited₹182.54 Cr (FY 2025)-7.0%Mumbai, Maharashtra, India
Molkem Chemicals Private Limited₹178.68 Cr (FY 2025)63.0%Ahmedabad, Gujarat, India
Medihauxe Pharma Private Limitedthis company₹175.69 Cr (FY 2023)₹2.19 Cr1.2%-4.0%67Hyderabad, Telangana, India
Indigo Health Care Private Limited₹175.16 Cr (FY 2025)40.0%Hyderabad, Telangana, India
Sundyota Numandis Pharmaceuticals Private Limited₹174.35 Cr (FY 2025)20.0%Ahmedabad, Gujarat, India
Anzen Exports Private Limited₹173.73 Cr (FY 2025)27.0%Kolkata, West Bengal, India

To see the full peer comparison of Medihauxe Pharma Private Limited, buy the company report.

Auditor

Medihauxe Pharma Private Limited is audited by M.Sreenivasulu Reddy & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M.Sreenivasulu Reddy & AssociatesFY 2023007400S

Shareholding

The shareholding of Medihauxe Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medihauxe Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹31 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹31.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Jul 2016100057346Hdfc Bank Limited₹1 CrSatisfied
20 Aug 201410536650Hdfc Bank Limited₹30 CrSatisfied

To see the full charge records of Medihauxe Pharma Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Medihauxe Pharma Private Limited has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in February 2016.

Total deals
4
Rights issues
3
Secondary share transfer
1

Deals on record (4 of 4)

WhenDealAmountParties
Feb 2016Rights issue₹50 LakhInvestors: Keimed Private Limited , 2 individuals
Feb 2015Secondary share transferUndisclosedBuyer: Keimed Private Limited
Seller: an individual
Nov 2014Rights issue₹4.25 CrInvestors: Keimed Private Limited , an individual
Jun 2014Rights issue₹14 LakhInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Medihauxe Pharma Private Limited was last rated by Care on 17 Dec 2021.

Rating agencyRated onRating
Care17 Dec 2021

To see the full credit ratings and regulatory alerts of Medihauxe Pharma Private Limited, buy the company report.

MSME payment delays

Medihauxe Pharma Private Limited has 2 MSME Form 1 returns on record between 2018 and 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Qren Lifesciences Private Limited
an individual supplier

To see the full MSME payment records of Medihauxe Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Medihauxe Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Medihauxe Pharmaceuticals Private LimitedU51909TG2022PTC160467

To see the full group structure of Medihauxe Pharma Private Limited, buy the company report.

Employees & EPFO

Medihauxe Pharma Private Limited has a workforce of 67 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.

Employee count
67
Active EPFO establishments
1
Employee growth
39.58%

GST

Medihauxe Pharma has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAJCM2250J1ZFTelanganaActive01 Jul 2017
37AAJCM2250J1ZDAndhra PradeshActive06 Jul 2017
32AAJCM2250J1ZNKeralaActive16 Aug 2021

To see the full GST registrations and return filing status of Medihauxe Pharma Private Limited, buy the company report.

Recent activity

Medihauxe Pharma Private Limited has 9 board changes on record since 2014: 4 appointments and 5 cessations. The latest: Yashwant Singh ceased to be Additional Director on 28 Jul 2021.

AGM
Medihauxe Pharma Private Limited last Annual general meeting of members was held on 08 Sep 2023 as per latest MCA records.
Charges
A charge registered on 11 Jul 2016 via Charge ID 100057346 with Hdfc Bank Limited was fully satisfied on 05 Aug 2023.
Charges
A charge registered on 20 Aug 2014 via Charge ID 10536650 with Hdfc Bank Limited was fully satisfied on 05 Aug 2023.
Filing
Medihauxe Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 30.00 Cr registered on 20 Aug 2014 with Charge ID 10536650 was modified on 07 Jun 2022.
Ceased
Yashwant Singh ceased to be Additional Director.
Appointed
Yashwant Singh was appointed as Director.
Ceased
Taruna Chimanlal Joshi ceased to be Director.
Ceased
Arvind Kumar Venkat ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100057346 was registered on 11 Jul 2016.
Appointed
Arvind Kumar Venkat was appointed as Nominee Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 30.00 Cr with Charge ID 10536650 was registered on 20 Aug 2014.

5 earlier events are in the company report.

Frequently asked questions

Medihauxe Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Medihauxe Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 May 2014 and is registered under CIN U24233TG2014PTC094068. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Medihauxe Pharma was incorporated on 16 May 2014. It is registered with the Registrar of Companies, Hyderabad.

Medihauxe Pharma had 4 directors:

The CIN (Corporate Identification Number) of Medihauxe Pharma is U24233TG2014PTC094068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Medihauxe Pharma is at Mig – 7A Mch No – 7 – 1 – 3971027A Near Community Hall S R Nagar, Hyderabad, Telangana, India – 500038.

Medihauxe Pharma can be reached through the website medihauxepharma.com. Its registered office is in Hyderabad, Telangana, India.

The latest financial statements of Medihauxe Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 08 September 2023. Year-wise statements from 2015 are in the company report.

The GSTIN of Medihauxe Pharma is 36AAJCM2250J1ZF, registered in Telangana. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 37AAJCM2250J1ZD (Andhra Pradesh), 32AAJCM2250J1ZN (Kerala).

Medihauxe Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment.

Medihauxe Pharma has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in February 2016.

The peers of Medihauxe Pharma by revenue are Dadha Pharma Distribution Limited, Molkem Chemicals Private Limited, Indigo Health Care Private Limited, Sundyota Numandis Pharmaceuticals Private Limited, Anzen Exports Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).